Apple Pay Later: What’s The Game Plan For Monetization?

Nikada/iStock via Getty Images Unpublished

 

Apple (NASDAQ:AAPL) has a suite of services to monetize its loyal customer base of high-end hardware devices. One of these services includes Apple Pay, a mobile payment service that facilitates in-person, online, and in-app (iOS) payments. Apple’s financial services ventures have become significant revenue-generators. The trend of payment solutions towards Buy Now, Pay Later (BNPL) has also prompted the tech behemoth to enter the field with the launch of its ‘Apple Pay Later’. Apple’s move into a fintech business model that has yet to prove its sustainability calls into question its long-term monetization plans in this space.

 

 

Related News

What is the BIOS and what is its function in a computer?

Computers have gone through a process of evolution that has led them to be increasingly accessible and understandable to users. However, there are aspects

4GB of memory? You can not imagine how much they have made Windows 11 work

One of the most criticized aspects of Windows 11, since its announcement, have been its minimum requirements. And it is that Windows had been sharing more or

New Android Auto 8.9 now available: how to download this first beta version

The development of Android Auto never stops. From beta we went to stable and from stable we went to beta. Android Auto 8.8 stable was official last week and

Online banks still grapple with cyber security flaws, says report computer weekly

Consumer organization which? The websites and mobile applications of some of the UK's most popular retail banks are riddled with security flaws, putting

Twitter’s ‘For You’ tab just got more useful on iOS and Android

If you primarily use Twitter on an iPhone or Android, like most of the world, the company has released an update that you'll be quite happy about.

Groundbreaking diabetes discovery brings world closer to life without insulin

Scientists at the University of Geneva (UNIGE) have been working for several years on an alternative therapy based on the S100A9 protein. (Credit: iStock photo)